Neuberger Berman Group
VNDA icon

Neuberger Berman Group’s Vanda Pharmaceuticals VNDA Stock Holding History

Neuberger Berman Group’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.5K Buy
+10,708
New +$69.9K ﹤0.01% 2273
2018
Q4 		– Sell
-45,500
Closed -$1.04M – 1659
2018
Q3 		$1.04M Buy
45,500
+15,500
+52% +$316K ﹤0.01% 1179
2018
Q2 		$572K Buy
+30,000
New +$502K ﹤0.01% 1366

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Neuberger Berman Group's VNDA Position: Q2 2026 in Review

Neuberger Berman Group opened a new position in Vanda Pharmaceuticals (VNDA) in Q2 2026: 10,708 shares worth $65.5K. The stake represents ﹤0.01% of the portfolio and ranks #2273 among its holdings. This is a return to the name: Neuberger Berman Group previously reported a position in VNDA as recently as Q3 2018.

Neuberger Berman Group first reported a position in VNDA in Q2 2018 and has held it in 3 quarters since. The position peaked at $1.04M in Q3 2018. 173 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Neuberger Berman Group held 10,708 shares of Vanda Pharmaceuticals worth $65.5K as of Q2 2026.
  • Vanda Pharmaceuticals was a new Neuberger Berman Group position in Q2 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #2273 holding.
  • Neuberger Berman Group first reported a position in Vanda Pharmaceuticals in Q2 2018 and has held it in 3 quarters since.
  • Neuberger Berman Group's Vanda Pharmaceuticals position peaked at $1.04M in Q3 2018.
  • 173 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.